Active enhancement of canine liver allografts with polyspecific antigen.
Of 34 canine liver allograft recipients, 17 in the control group survived for 6.9 +/- 1.5 days. Six recipients, group 3, were given 780 milligrams per kilogram of body weight polyspecific semisoluble antigen prepared from 20 spleens together with 10 milligrams per kilogram of body weigth prednisolone on days 15, 8 and 1 before transplantation. The mean survival time of this group was 10.1 +/- 2.0 days, p less than 0.01, compared with the control group. Six other recipients, group 4, were similarly treated with antigen from a pool of 70 spleens. Three survived for more than three weeks, and the other three died on days 1, 7 and 8 postoperatively with signs of accelerated rejection. Donors and recipients were not identical for leukocyte defined determinants. The recipients displaying accelerated rejection had markedly higher lymphocytotoxic and hemagglutinating antibodies. In addition, all recipients undergoing progressive rejection showed an inhibition of leukocyte migration. After three antigen dosages, rosette forming lymphocytes were present in increased numbers in peripheral blood and remained unchanged thereafter.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D003601:Cytotoxicity Tests, Immunologic; D004285:Dogs; D000939:Epitopes; D006085:Graft Survival; D008099:Liver / Q000276:immunology; D016031:Liver Transplantation; D007959:Lymphocyte Culture Test, Mixed; D012397:Rosette Formation; D013154:Spleen / Q000276:immunology; D013997:Time Factors; D014184:Transplantation, Homologous
D000906:Antibodies; D000939:Epitopes